Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disrupting HIT immune complexes as a new treatment for HIT.

Blood·2025
Same author

Regulatory Effect of PDGF/PDGFR on Hematopoiesis.

Seminars in thrombosis and hemostasis·2024
Same author

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments.

Blood advances·2024
Same author

Determination of Antibody Activity by Platelet Aggregation.

Bio-protocol·2023
Same author

NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia.

Nature communications·2022
Same author

Circulating platelet-neutrophil aggregates characterize the development of type 1 diabetes in humans and NOD mice.

JCI insight·2022

Related Experiment Video

Updated: May 9, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

HIT: nucleic acid masquerading as heparin.

Beng H Chong1, James J-H Chong

  • 1New South Wales University.

Blood
|July 13, 2013
PubMed
Summary
This summary is machine-generated.

Heparin-PF4 antibodies can activate platelets through nucleic acid-PF4 complexes. This finding suggests a potential new cause for heparin-induced thrombocytopenia-like disorders.

More Related Videos

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase
07:50

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

Published on: December 8, 2017

Related Experiment Videos

Last Updated: May 9, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase
07:50

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

Published on: December 8, 2017

Area of Science:

  • Hematology
  • Immunology
  • Thrombosis

Background:

  • Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated complication of heparin therapy.
  • Platelet factor 4 (PF4) is a key antigen in HIT pathogenesis.
  • The precise mechanisms triggering HIT remain under investigation.

Purpose of the Study:

  • To investigate the cross-reactivity of heparin-PF4 antibodies with other complexes.
  • To determine if nucleic acid-PF4 complexes can induce platelet activation.
  • To explore potential novel prothrombotic mechanisms.

Main Methods:

  • ELISA assays to detect antibody binding.
  • Platelet activation assays using patient sera.
  • Analysis of antibody cross-reactivity with various complexes.

Main Results:

  • Heparin-PF4 antibodies demonstrated cross-reactivity with nucleic acid-PF4 complexes.
  • These cross-reactive antibodies induced significant platelet activation.
  • Nucleic acid-PF4 complexes were identified as potential targets for HIT-related antibodies.

Conclusions:

  • Nucleic acid-PF4 complexes may play a role in heparin-induced thrombocytopenia (HIT).
  • This cross-reactivity suggests a potential mechanism for a HIT-like prothrombotic disorder.
  • Further research is warranted to elucidate the clinical significance of NA-PF4 complexes in thrombosis.